Atea Pharmaceuticals is trading 5.81% down at $5.35, with broader U.S. markets also lower amid geopolitical and energy-price concerns.
- No company-specific announcement, filing, clinical update, regulatory action, or analyst catalyst was identified on September 9, 2026.
- The latest disclosed item was a September 8 conference presentation announcement.
- Volume is approximately 207.39K versus a 202.06K average, indicating roughly average activity.